Trinity Biotech Plc (TRIB)-Product Pipeline Analysis, 2016 Update

Trinity Biotech Plc (TRIB)-Product Pipeline Analysis, 2016 Update


  • Products Id :- GDME1018PD
  • |
  • Pages: 51
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Trinity Biotech Plc (Trinity Biotech) is a medical equipment company which develops, acquires, manufactures and distributes diagnostic systems for clinical laboratory and point-of-care sectors. The company's product portfolio encompasses diagnostic tests and instruments that are used to detect haemoglobin A1c for diabetes monitoring and diagnosis, infectious diseases, autoimmune, sexually transmitted diseases, liver and intestine disorders. It also offers raw materials to research and life sciences sectors. Trinity Biotech markets its products through direct sales in the US, Germany, France and the UK; and through a network of distributors and strategic partnerships in other countries. The company has manufacturing facilities in the US and Ireland. Trinity Biotech is headquartered in Co. Wicklow, Ireland.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

The report analyzes all pipeline products in development for the company Trinity Biotech Plc

The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

The report provides detailed description of products in development, technical specification and functions

The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons To Buy:

Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

To formulate effective Research & Development strategies

Develop market-entry and market expansion strategies

Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc

Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Trinity Biotech Plc Company Snapshot 6

Trinity Biotech Plc Company Overview 6

Trinity Biotech Plc Pipeline Products and Clinical Trials Overview 7

Trinity Biotech Plc-Pipeline Analysis Overview 10

Business Description 10

Key Facts 11

Trinity Biotech Plc-Major Products and Services 12

Trinity Biotech Plc Pipeline Products by Development Stage 13

Trinity Biotech Plc Pipeline Products Overview 15

BNP Test-POC 15

BNP Test-POC Product Overview 15

D-dimer Test 16

D-dimer Test Product Overview 16

Diagnostic Assay-Dengue 17

Diagnostic Assay-Dengue Product Overview 17

Diagnostic Test-Adenovirus/Rotavirus 18

Diagnostic Test-Adenovirus/Rotavirus Product Overview 18

Meritas Point of Care Analyzer 19

Meritas Point of Care Analyzer Product Overview 19

Meritas Troponin I Test 20

Meritas Troponin I Test Product Overview 20

Multiplex Cardiac Panel 21

Multiplex Cardiac Panel Product Overview 21

Uni-Gold Chlamydia Test 22

Uni-Gold Chlamydia Test Product Overview 22

Uni-Gold Faecal Occult Blood Test 23

Uni-Gold Faecal Occult Blood Test Product Overview 23

Uni-Gold H. pylori Ag Test 24

Uni-Gold H. pylori Ag Test Product Overview 24

Uni-Gold HIV Ag/Ab Combo Test 25

Uni-Gold HIV Ag/Ab Combo Test Product Overview 25

Uni-Gold Infectious Mononucleosis Test 26

Uni-Gold Infectious Mononucleosis Test Product Overview 26

Uni-Gold Malaria Test 27

Uni-Gold Malaria Test Product Overview 27

Uni-Gold RSV Test 28

Uni-Gold RSV Test Product Overview 28

Uni-Gold S. Pneumoniae Test 29

Uni-Gold S. Pneumoniae Test Product Overview 29

Uni-Gold Strep B Test 30

Uni-Gold Strep B Test Product Overview 30

Uni-Gold Syphilis-Combo 31

Uni-Gold Syphilis-Combo Product Overview 31

Uni-Gold Tuberculosis Test 32

Uni-Gold Tuberculosis Test Product Overview 32

Trinity Biotech Plc-Key Competitors 33

Trinity Biotech Plc-Key Employees 34

Trinity Biotech Plc-Key Employee Biographies 35

Trinity Biotech Plc-Locations And Subsidiaries 36

Head Office 36

Other Locations & Subsidiaries 36

Recent Developments 38

Trinity Biotech Plc, Recent Developments 38

Apr 19, 2016: Trinity Biotech Announces Results for Q1, 2016 38

Mar 03, 2016: Trinity Biotech Announces Results for Q4 and Fiscal Year 2015 39

Dec 17, 2015: Trinity Biotech Announces FDA Submission of High Sensitivity Troponin I Product 41

Jul 28, 2015: Trinity Biotech Announces Quarter 2 Financial Results Enrolment for the Meritas Troponin ACS Study Now Completed 41

Apr 30, 2015: Trinity Biotech Announces Quarter 1 Results -- EPS 17.4 Cents Dividend of 22 Cents 43

Mar 03, 2015: Trinity Biotech Announces Results for Q4 and Fiscal Year 2014 45

Feb 23, 2015: Trinity Biotech Announces Recommencement of US Clinical Trials on its Point-of-Care, High Sensitivity Troponin I Product 47

Dec 16, 2014: Trinity Biotech Announces CLIA Waiver of Rapid Syphilis Test 48

Oct 23, 2014: Trinity Biotech announces Quarter 3 Financial Results 48

Oct 23, 2014: Trinity Biotech Provides Update On Sales Of Premier In Q3 2014 50

Appendix 51

Methodology 51

About GlobalData 51

Contact Us 51

Disclaimer 51

List of Figures

Trinity Biotech Plc Pipeline Products by Equipment Type 8

Trinity Biotech Plc Pipeline Products by Development Stage 13

List of Tables

Trinity Biotech Plc Pipeline Products and Clinical Trials Overview 7

Trinity Biotech Plc Pipeline Products by Equipment Type 7

Trinity Biotech Plc Pipeline Products by Indication 9

Trinity Biotech Plc, Key Facts 11

Trinity Biotech Plc, Major Products and Services 12

Trinity Biotech Plc Number of Pipeline Products by Development Stage 13

Trinity Biotech Plc Pipeline Products Summary by Development Stage 14

BNP Test-POC-Product Status 15

BNP Test-POC-Product Description 15

D-dimer Test-Product Status 16

D-dimer Test-Product Description 16

Diagnostic Assay-Dengue-Product Status 17

Diagnostic Assay-Dengue-Product Description 17

Diagnostic Test-Adenovirus/Rotavirus-Product Status 18

Diagnostic Test-Adenovirus/Rotavirus-Product Description 18

Meritas Point of Care Analyzer-Product Status 19

Meritas Point of Care Analyzer-Product Description 19

Meritas Troponin I Test-Product Status 20

Meritas Troponin I Test-Product Description 20

Multiplex Cardiac Panel-Product Status 21

Multiplex Cardiac Panel-Product Description 21

Uni-Gold Chlamydia Test-Product Status 22

Uni-Gold Chlamydia Test-Product Description 22

Uni-Gold Faecal Occult Blood Test-Product Status 23

Uni-Gold Faecal Occult Blood Test-Product Description 23

Uni-Gold H. pylori Ag Test-Product Status 24

Uni-Gold H. pylori Ag Test-Product Description 24

Uni-Gold HIV Ag/Ab Combo Test-Product Status 25

Uni-Gold HIV Ag/Ab Combo Test-Product Description 25

Uni-Gold Infectious Mononucleosis Test-Product Status 26

Uni-Gold Infectious Mononucleosis Test-Product Description 26

Uni-Gold Malaria Test-Product Status 27

Uni-Gold Malaria Test-Product Description 27

Uni-Gold RSV Test-Product Status 28

Uni-Gold RSV Test-Product Description 28

Uni-Gold S. Pneumoniae Test-Product Status 29

Uni-Gold S. Pneumoniae Test-Product Description 29

Uni-Gold Strep B Test-Product Status 30

Uni-Gold Strep B Test-Product Description 30

Uni-Gold Syphilis-Combo-Product Status 31

Uni-Gold Syphilis-Combo-Product Description 31

Uni-Gold Tuberculosis Test-Product Status 32

Uni-Gold Tuberculosis Test-Product Description 32

Trinity Biotech Plc, Key Employees 34

Trinity Biotech Plc, Key Employee Biographies 35

Trinity Biotech Plc, Subsidiaries 36

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Thermo Fisher Scientific Inc.

Siemens Healthcare GmbH

Roche Diagnostic Systems Molecular Systems

OraSure Technologies, Inc.

Johnson & Johnson Health Care Systems Inc.

Bio-Rad Laboratories, Inc.

Beckman Coulter, Inc.

Abbott Diagnostics

Trinity Biotech Plc, Product, Pipeline, Product Pipeline, Key Pipeline, Products by Equipment Type, Equipment Type, Therapy Area, Products by Therapy Area, Development Stage, Products by Development Stage, Milestone, Products by Milestone, Major Products, Brands, No of Products, Device Class, Market, Territory, Product Name, Therapy Name, Trial Name, Trial, Indication, Summary, Event Type, Clinical Trial, MileStone, Product Status, Product Description, Description, Patent, Patent Details, Competitors, Key Employees, Subsidiaries, Locations, News, Events, Developments, medical devices, business description, company facts, trial phase, approval, estimated, technology, product patent details, phase, trial status, trial objective, trial design, trial site, business strategies, trends, pipeline and technology, sales strategies

select a license

Single User License
USD 750 INR 48428
Site License
USD 1500 INR 96855
Corporate User License
USD 2250 INR 145283

NEWSLETTER BY CATEGORY




Testimonials

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies....

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ...

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!...



Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

query [@] kenresearch.com